Literature DB >> 3146541

The pituitary-thyroid axis in acromegaly.

P C Eskildsen1, A Kruse, C Kirkegaard.   

Abstract

The pituitary-thyroid axis of 12 acromegalic patients was evaluated by measurement of the serum concentrations (total and free) of thyroxine (T4), triiodothyronine (T3) and reverse T3 (rT3) and thyrotropin (TSH), growth hormone (GH) and prolactin (PRL) before and after iv stimulation with thyrotropin releasing hormone (TRH). Using an ultrasensitive method of TSH measurement (IRMA) basal serum TSH levels of the patients (0.76, 0.07-1.90 mIU/l) were found slightly, but significantly (P less than 0.01), lower than in 40 healthy controls (1.40, 0.41-2.50 mIU/l). The total T4 levels (TT4) were also reduced (84, 69-106 nmol/l vs 100, 72-156 nmol/l, P less than 0.01) and significantly correlated (P less than 0.02, R = 0.69) to the TSH response to TRH, suggesting a slight central hypothyroidism. The acromegalics had, however, normal serum levels of TT3 (1.79, 1.23-2.52 nmol/l vs 1.74, 0.78-2.84 nmol/l, P greater than 0.10), but significantly decreased levels of TrT3 (0.173, 0.077-0.430 nmol/l vs 0.368, 0.154-0.584 nmol/l, P less than 0.01) compared to the controls. The serum concentration of the free iodothyronines (FT4, FT3, FrT3) showed similar differences between acromegalics and normal controls. All the acromegalics showed a rise of serum TSH, GH and PRL after TRH. Positive correlation (P less than 0.05, R = 0.59) was found between the TSH and GH responses, but not between these two parameters and the PRL response to TRH. These findings may be explained by the existence of a central suppression of the TSH and GH secretion in acromegalic subjects, possibly exerted by somatostatin. Euthyroidism might be maintained by an increased extrathyroidal conversion of T4 to T3.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146541     DOI: 10.1055/s-2007-1010940

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  5 in total

Review 1.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

2.  Thyroid volume and function in patients with acromegaly living in iodine deficient areas.

Authors:  R Junik; J Sawicka; W Kozak; M Gembicki
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

3.  Thyroid autoimmune disorders in patients with acromegaly.

Authors:  M Manavela; C Vigovich; K Danilowicz; A Juri; L Miechi; V Fernandez Valoni; O D Bruno
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

4.  Thyroid diseases in patients with acromegaly.

Authors:  Anna Maria Dąbrowska; Jerzy Stanisław Tarach; Maria Kurowska; Andrzej Nowakowski
Journal:  Arch Med Sci       Date:  2013-08-12       Impact factor: 3.318

5.  GH, IGF-1, and Age Are Important Contributors to Thyroid Abnormalities in Patients with Acromegaly.

Authors:  Xia Wu; Lu Gao; Xiaopeng Guo; Qiang Wang; Zihao Wang; Wei Lian; Wei Liu; Jian Sun; Bing Xing
Journal:  Int J Endocrinol       Date:  2018-01-15       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.